Patents Assigned to VELO BIO, LLC
  • Publication number: 20160039917
    Abstract: Methods for detecting patients with eclampsia or preeclampsia by detecting of EDLF in a patient. Methods for screening patients that may be responsive to anti-digoxin antibody therapy are also described. Systems for detecting EDLF include nanowire biosensors.
    Type: Application
    Filed: March 17, 2014
    Publication date: February 11, 2016
    Applicant: VELO BIO, LLC
    Inventor: Charles David ADAIR